Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-01, Stock:NVS, The news for the past five days is as follows:
2019-06-24: NEWS1: UPDATE 1-Conatus Pharma to explore options as liver disease drug fails trial.
2019-06-25: NEWS1: Health Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS.NEWS2: Health Care Sector Update for 06/25/2019: BPMX,AGN,ABBV,CNAT,NVS.NEWS3: Novartis wins Gilenya reprieve as judge blocks generics, for now.
2019-06-26: NEWS1: Is Allergan a Good Deal for AbbVie?.NEWS2: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS3: Conatus' Emricasan Lags Primary Goal in Liver Function Study.NEWS4: Conatus' Emricasan Lags Primary Goal in Liver Function Study.
2019-06-27: NEWS1: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS2: Dova Receives Approval for Doptelet in Europe, Stock Up.NEWS3: Dova Receives Approval for Doptelet in Europe, Stock Up.NEWS4: FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review.NEWS5: FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review.NEWS6: FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review.NEWS7: Dova Receives Approval for Doptelet in Europe, Stock Up.NEWS8: Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits.NEWS9: Is Allergan a Good Deal for AbbVie?.
2019-06-28: NEWS1: Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View.NEWS2: Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View.NEWS3: Amgen's Osteoporosis Drug Evenity Gets Adverse CHMP View.

Answer: Rise